When a deal deserves a closer look, RepUp shows the manager exactly what is happening — not a summary, but the actual signals. The deal risk board scores health across 8 metrics, call intelligence surfaces the last conversation's key moments, the stakeholder coverage map shows who is engaged and who went quiet, and the qualification scorecard shows which MEDDICC elements are validated versus assumed.
What it helps with
- Risk diagnosis: the deal risk board shows which of the 8 health metrics are declining — engagement recency dropped, stakeholder coverage is single-threaded, next step quality scored low, close date slipped twice.
- Call evidence: call intelligence surfaces the specific moment from the last conversation — did the rep confirm budget? Did they engage the economic buyer? Did they set a concrete next step?
- Qualification gaps: the MEDDICC scorecard shows which elements are validated with evidence and which are marked "TBD" — so the manager coaches to the specific gap, not the whole framework.
Why it matters
- Before: the manager asks "how's the Acme deal?" and gets a 5-minute verbal summary. After: the manager opens the deal card, sees engagement dropped 35%, the champion has not responded in 12 days, and the last call had no discussion of decision criteria — and starts the conversation there.
- Before: coaching is "you need to push this deal forward." After: coaching is "on the call with their Director of Ops, you didn't ask about the paper process — and that's the open gap blocking this deal from moving to stage 4."
- Before: the review is status. After: the deal inspection surfaces the specific action — multi-thread to the VP, confirm budget on the next call, set a demo with the technical evaluator.
Related reading
- Deal inspection framework — a step-by-step approach to evaluating deal health.
- Deal Risk Board — the feature that flags at-risk deals before the forecast review.